In acute myeloid leukemia, the expression level of galectin-12 is downregulated (88.7% downregulation compared to normal controls) and patients with lower galectin-12 levels have a lower survival rate compared to those with higher galectin-12 levels [7]. This evidence concerns the gene LGALS12 and acute myeloid leukemia.